Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4065570)

Published in J Psychosom Res on April 22, 2014

Authors

Dominic Dougall1, Anthony Johnson2, Kimberley Goldsmith3, Michael Sharpe4, Brian Angus5, Trudie Chalder6, Peter White7

Author Affiliations

1: East London Foundation NHS Trust, London, UK.
2: MRC Clinical Trials Unit at UCL, London, UK.
3: Biostatistics Department, Institute of Psychiatry, King's College London, UK.
4: Psychological Medicine Research, Department of Psychiatry, University of Oxford, Oxford, UK.
5: Nuffield Department of Medicine, University of Oxford, UK.
6: Academic Department of Psychological Medicine, King's College London, UK.
7: Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: p.d.white@qmul.ac.uk.

Articles cited by this

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02

The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73

Development of a fatigue scale. J Psychosom Res (1993) 10.16

A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70

Effect of a self-management program on patients with chronic disease. Eff Clin Pract (2001) 7.46

The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry (2010) 6.88

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med (2002) 6.10

Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93

A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol (1988) 4.47

Chronic fatigue syndrome. Lancet (2006) 4.15

Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med (2003) 2.90

Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord (2003) 1.85

Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. BMC Neurol (2007) 1.79

Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res (2008) 1.54

A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res (2004) 1.46

Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res (2009) 1.41

Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med (2007) 1.25

Unexplained physical symptoms: outcome, utilization of medical care and associated factors. Psychol Med (1996) 1.08

Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: a review of current practice. Contemp Clin Trials (2014) 1.05

Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. Eur J Clin Pharmacol (2008) 0.98

Diurnal cortisol secretion and 2-year changes in older adults' physical symptoms: the moderating roles of negative affect and sleep. Health Psychol (2008) 0.96

Depression and anxiety in patients repeatedly referred to secondary care with medically unexplained symptoms: a case-control study. Psychol Med (2011) 0.93

Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern. Fam Pract (2010) 0.91

Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. Psychiatry Res (2004) 0.89

Long-term sickness absence among patients with chronic fatigue syndrome. Br J Psychiatry (2011) 0.88

The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. J Clin Psychopharmacol (1995) 0.87

Personality characteristics of volunteers in Phase 1 studies and likelihood of reporting adverse events. Int J Clin Pharmacol Ther (2008) 0.79

Personality influences the reporting of side effects of inhaled corticosteroids in asthma patients. J Asthma (2008) 0.78